SCHEMBL26519035

SCHEMBL26519035

c1ccc([Si](c2ccccc2)(c2ccccc2)c2ccc3c(c2)c2ccccc2n3-c2ccc3c(c2)c2ccccc2n3-c2ccccc2-c2ccccc2-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 1/20 0.36
RAC2 P15153 1/20 0.32
RAC3 P60763 1/20 0.32
CDC42 P60953 1/20 0.32
RAC1 P63000 1/20 0.32
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31
PTPN1 P18031 1/20 0.31
TDO2 P48775 2/20 0.30
IDO2 Q6ZQW0 2/20 0.30
NPC1 O15118 1/20 0.30
LMNA P02545 1/20 0.30
NTRK1 P04629 1/20 0.30
ALOX5 P09917 1/20 0.30
MAPT P10636 1/20 0.30
IDO1 P14902 1/20 0.30
PTGS2 P35354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26519046 1.00 KDM4E (0.40) KDM4EATML3MBTL1ALDH1A1RAC2
SCHEMBL25449243 1.00 KDM4E (0.40) KDM4EATML3MBTL1ALDH1A1RAC2
SCHEMBL26519041 1.00 KDM4E (0.40) KDM4EATML3MBTL1ALDH1A1RAC2
SCHEMBL26519042 1.00 KDM4E (0.40) KDM4EATML3MBTL1ALDH1A1RAC2
SCHEMBL26519193 0.96 KDM4E (0.41) KDM4EATML3MBTL1ALDH1A1RAC2
SCHEMBL26519015 0.96 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1RAC2
SCHEMBL25449241 0.95 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1RAC2
SCHEMBL26519020 0.95 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1RAC2
SCHEMBL24398145 0.95 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1RAC2
SCHEMBL26519018 0.95 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1RAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240244857-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244857-A1 ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND LG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20230329089-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-12 US disclosed
US-20230329089-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230329089-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NR1H2, OXER1, NR1H3 KDM4E 2635/4885ATM 4242/4885L3MBTL1 2221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.